Cryotherapy Market is estimated to be valued at USD 365.4 Mn in 2025 and is expected to reach USD 773.1 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.
The cryotherapy market demand continues to grow steadily as medical, wellness, and athletic sectors increasingly adopt its use. Healthcare providers and wellness centers actively use cryotherapy to treat cancer, pain, skin conditions, and inflammation. Hospitals, clinics, and fitness facilities are expanding their cryotherapy services. Ongoing innovations in cryoablation devices, greater awareness of minimally invasive procedures, and rising demand for wellness treatments are fueling this growth.
|
Current Events |
Description and its impact |
|
Geopolitical Developments |
|
|
Economic Factors |
|
|
Healthcare Trends and Public Awareness |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Actinic keratosis and benign lesion removal are billed using CPT codes 17000, 17003, 17004, 17110, and 17111, as outlined by the American Academy of Family Physicians. These are standard for cryosurgical destruction of premalignant and benign lesions.
Aetna’s clinical policy covers specific CPT codes such as 55873 (prostate), 50593/50250 (renal tumors), 32994 (lung), 57511 (cervical), and neuroablations and retinal cryotherapy codes—when selection criteria are met and documented appropriately.
Cryosurgery devices hold a dominant share of 36.2% in 2025. Healthcare providers are rapidly adopting cryosurgery devices as they prioritize minimally invasive treatments for oncology, dermatology, and pain management that minimize bleeding, scarring, and recovery time. Clinics are turning to cryoablation tools in response to rising cases of cancer and skin lesions. Manufacturers continue to develop portable systems, image-guided probes, and automated controls that enhance accuracy and usability. As outpatient surgical centers grow and awareness of cryosurgery's advantages spreads, hospitals and clinics actively invest in advanced cryosurgical technologies.
For instance, BVI, one of the fastest growing diversified ophthalmology companies, has launched CryoTreq in Europe—the world’s first handheld, single-use cryo-surgery device designed specifically for ophthalmology, further accelerating the cryotherapy market demand.
With the global rise in cancer cases, healthcare professionals are turning more often to cryotherapy to treat cancers like skin, prostate, breast, cervical, bone, and retinoblastoma. They rely on cryoablation to precisely freeze tumors, protect surrounding healthy tissue, and shorten hospital stays. To enhance accuracy, manufacturers are developing advanced probes, improved imaging systems, and finer needles for cryotherapy devices. As awareness grows among doctors and patients about less invasive cancer treatments, the use of cryotherapy in oncology continues to expand rapidly.
For instance, EVERSANA®, a leading life sciences commercialization services provider, has partnered with ChemoMouthpiece, LLC to support the launch and commercialization of the Chemo Mouthpiece™ medical device across the United States. The device, an intraoral ice pack, delivers cryotherapy to the oral cavity for patients undergoing chemotherapy.
Hospitals are actively the cryotherapy market growth by leveraging their advanced clinical infrastructure and skilled medical staff. They use cryotherapy across a range of specialties—including oncology, dermatology, cardiology, and pain management—establishing it as a reliable treatment method. Manufacturers continue to equip hospitals with improved cryotherapy systems featuring precision probes and integrated imaging. With growing institutional awareness, clearer clinical protocols, and supportive reimbursement policies, hospitals are expanding their use of cryotherapy, prompting broader adoption across the healthcare sector and accelerating overall market growth.
For instance, Mahdia Hospital has received a cryotherapy machine to treat early signs of cervical cancer and other abnormalities. Medical staff will use the device to perform cryotherapy, also known as cryosurgery, which is widely recognized as an effective and practical method for treating precancerous cervical lesions globally.
To learn more about this report, Download Free Sample
North America holds a 33.50% of the total market share in 2025. North America continues to lead cryotherapy adoption as healthcare providers, wellness clinics, and fitness centers actively use it for sports recovery, pain relief, and aesthetic treatments. Athletes and trainers rely on cryochambers and cryosaunas to enhance performance and speed up recovery. Manufacturers are developing portable systems with smart monitoring and precision probes to improve functionality. Rising awareness of cryotherapy’s benefits, along with strong healthcare systems in the U.S. and Canada, is driving its growth, while Canada is steadily increasing their usage across various sectors. In September 2024, InfuSystem Holdings, Inc., a leading national healthcare services provider supporting outpatient care for durable medical equipment manufacturers and healthcare providers, along with its joint venture partner Sanara MedTech Inc. (“Sanara”), announced that they have signed an exclusive U.S. distribution agreement with ChemoMouthpiece, LLC for an oral cryotherapy device.
Hospitals and clinics throughout Europe are increasingly using cryotherapy to treat cancers—such as skin, prostate, bone, and cervical—and to manage pain. Medical professionals prefer cryoablation for its minimally invasive nature, which shortens hospital stays and protects healthy tissue. Germany drives the market with its aging population, advanced healthcare system, and tech-savvy patients. In Poland, physiotherapy centers widely adopt cryochambers, while Spain and France expand usage through growing wellness tourism, higher disposable income, and greater integration of cryotherapy into healthcare services.
Consumers across the U.S. actively use cryotherapy in spas, gyms, and wellness centers for recovery, aesthetic enhancement, and inflammation relief. Increasing disposable income and celebrity influence have helped establish cryotherapy as a popular wellness trend. U.S. manufacturers continue to drive innovation by developing portable devices with smart monitoring, advanced cryoprobes, automated features, and integrated imaging—improving both safety and user experience in clinical and lifestyle settings. For instance, U.S. based company Gatan launched 'Alpine', the first direct detection camera designed to democratize cryo-electron microscopy imaging. By using a sensor optimized for 100–200 keV, Gatan enables high-resolution cryo-EM research on more accessible, cost-effective instruments, making advanced imaging capabilities available to a broader segment of the research community.
In China’s Tier 1 cities, awareness of cryotherapy is rapidly increasing, with nearly 39% of hospitals applying it for wound healing and inflammation management. This swift urban adoption sets China apart from markets with slower growth. Private wellness and luxury spa chains actively market cryotherapy as a premium recovery and anti-aging service, expanding the consumer base and emphasizing China’s unique emphasis on luxury wellness.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 365.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.3% | 2032 Value Projection: | USD 773.1 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Zimmer MedizinSysteme GmbH, Boston Scientific Corporation, Mectronic Medicale S.r.l., Impact Cryotherapy, C A Manufacturing Sp zoo, Cortex Technology, CooperSurgical Inc., Brymill Cryogenic Systems, Stryker, Cryoswiss GmbH, CryoConcepts LP., Medtronic, METRUM CRYOFLEX Sp. z o.o., CryoBuilt, Inc., Advanced Monitors Corporation, STERIS, DJO, LLC, and Pregna International Limited |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Cryotherapy gains widespread use in sports medicine and wellness centers, driven by athletes and fitness enthusiasts seeking faster recovery and inflammation reduction. Whole-body cryotherapy and localized treatments are popular for muscle repair, pain management, and enhancing athletic performance. Wellness clinics also promote cryotherapy for skin rejuvenation and anti-aging benefits. This trend fuels demand for advanced cryosaunas and cryochambers tailored for both professional and consumer use.
Cryotherapy presents growing opportunities in oncology as a minimally invasive alternative for tumor ablation in cancers like prostate, breast, and skin. Advancements in cryoablation devices and imaging integration enable precise targeting, reducing complications and recovery times. Increased physician acceptance and patient preference for less invasive treatments open new clinical applications and drive demand for specialized cryotherapy equipment.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
